LabCorp
LH
#819
Rank
HK$233.37 B
Marketcap
HK$2,874
Share price
0.90%
Change (1 day)
41.53%
Change (1 year)
Laboratory Corporation of America Holdings or LabCorp is a US company that offers clinical laboratory services. The company supplies laboratory results for the diagnosis of diseases and the development of new drugs.

P/E ratio for LabCorp (LH)

P/E ratio as of November 2026 (TTM): 29.9

According to LabCorp's latest financial reports and stock price the company's current price-to-earnings ratio (TTM) is 29.8753. At the end of 2022 the company had a P/E ratio of 16.9.

P/E ratio history for LabCorp from 2001 to 2023

PE ratio at the end of each year

Year P/E ratio Change
202216.932.24%
202112.80.17%
202012.8-36.48%
201920.138.49%
201814.512.69%
201712.9-29.3%
201618.2-36.37%
201528.660.04%
201417.925.8%
201314.20.27%
201214.2-14.32%
201116.52.4%
201016.210.41%
200914.6-3.89%
200815.2-17.95%
200718.6-11.85%
200621.113.37%
200518.6-3.09%
200419.216.16%
200316.527.05%
200213.0-58.41%
200131.2

P/E ratio for similar companies or competitors

Company P/E ratio P/E ratio differencediff. Country
IDEXX Laboratories
IDXX
47.2 57.91%๐Ÿ‡บ๐Ÿ‡ธ USA
Quest Diagnostics
DGX
25.1-15.95%๐Ÿ‡บ๐Ÿ‡ธ USA
Translate Bio
TBIO.defunct
N/AN/A๐Ÿ‡บ๐Ÿ‡ธ USA
NeoGenomics
NEO
-67.4-325.47%๐Ÿ‡บ๐Ÿ‡ธ USA
Qiagen
QGEN
25.4-15.12%๐Ÿ‡ณ๐Ÿ‡ฑ Netherlands
Enzo Biochem
ENZB
-3.33-111.14%๐Ÿ‡บ๐Ÿ‡ธ USA

How to read a P/E ratio?

The Price/Earnings ratio measures the relationship between a company's stock price and its earnings per share. A low but positive P/E ratio stands for a company that is generating high earnings compared to its current valuation and might be undervalued. A company with a high negative (near 0) P/E ratio stands for a company that is generating heavy losses compared to its current valuation.

Companies with a P/E ratio over 30 or a negative one are generaly seen as "growth stocks" meaning that investors typically expect the company to grow or to become profitable in the future.
Companies with a positive P/E ratio bellow 10 are generally seen as "value stocks" meaning that the company is already very profitable and unlikely to strong growth in the future.